{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nPIM1 is a constitutively active serine/threonine kinase with unique structural features—including an atypical hinge region and an unconventional ATP‐binding pocket—that distinguish it from other kinases. Crystallographic and peptide library studies have revealed these structural peculiarities and substrate recognition properties, providing the biochemical foundation for its persistent activity."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "5"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nAt the cellular level, PIM1 exerts its oncogenic potential by modulating critical cell cycle regulators. It phosphorylates the cyclin‐dependent kinase inhibitor p27^Kip1—promoting its binding to 14-3-3 proteins, nuclear export, and proteasomal degradation—as well as p21, altering its subcellular localization and stability. In addition, direct phosphorylation of proteins such as Cdc25C and complexing with mitotic apparatus components like NuMA further facilitates progression through the G2/M transition, thereby overriding normal cell cycle checkpoints."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "6", "end_ref": "10"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn addition to direct cell cycle control, PIM1 functions as a cofactor for oncogenic transcription. It cooperates with MYC by being recruited to E-box–containing promoters, where it phosphorylates histone H3 at serine 10 to promote MYC-target gene transcription. Such cooperation has been implicated in enhanced transformation and aggressive phenotypes in cancers such as triple-negative breast cancer."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "11", "end_ref": "13"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn malignant settings, overexpression or gene amplification of PIM1 underpins enhanced survival and drug resistance. For example, increased copy number and expression in triple-negative breast cancer, as well as aberrant phosphorylation of drug efflux transporters (e.g. BCRP) in prostate cancer cells, render tumors less susceptible to chemotherapeutics. In addition, oncogenic signaling cascades such as those activated by mutant Jak2 require PIM1 to sustain downstream effectors like STAT5 and MYC, thereby further embedding PIM1 in resistant and proliferative networks."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "14", "end_ref": "17"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nPIM1 also performs protective roles in nonmalignant contexts, notably within the cardiovascular system. In the myocardium, its expression is re‐induced in response to injury and stress, where it promotes cardiomyocyte survival by inhibiting apoptosis, preserving mitochondrial integrity, and enhancing calcium regulation. These mechanisms contribute to cardioprotection and improved cardiac function under pathologic conditions."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "18", "end_ref": "20"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nPost-transcriptional regulation plays a critical role in modulating PIM1 levels. Several microRNAs—including miR-33a, miR-486-5p, and miR-124-3p—have been shown to directly target the PIM1 mRNA, thereby suppressing its translation and downstream oncogenic effects. In addition, the presence of a stable G-quadruplex structure in the 3′ untranslated region of PIM1 mRNA acts as a translational repressor, further underscoring the importance of RNA-mediated control in limiting PIM1 overexpression."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "21", "end_ref": "23"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nWithin the immune system, PIM1 influences cell survival and function. In regulatory T cells, it phosphorylates FOXP3, diminishing its chromatin binding and modulating immunosuppressive gene expression. Similarly, in basophils, cytokine stimulation (e.g. by IL-3) induces PIM1 expression, thereby promoting cell survival through pathways involving p38 MAPK."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "24"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nClinical studies have further correlated elevated PIM1 levels with adverse outcomes across a range of malignancies. High PIM1 expression is associated with aggressive forms of prostate, colon, pancreatic, and head and neck cancers, and it also plays a role in hematologic malignancies such as T-cell acute lymphoblastic leukemia via IL-7/STAT5 signaling. Moreover, tumor hypoxia may lead to reduced microRNA-mediated repression of PIM1, further enhancing its expression and promoting tumor aggressiveness."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "26", "end_ref": "32"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nPIM1 is further embedded in feedback regulatory loops that sustain oncogenic signaling. It phosphorylates Mdm2, thereby altering p53 turnover and activity, and it contributes to the stabilization and aberrant signaling of growth factor receptors such as FLT3 in malignant cells. These interactions not only consolidate PIM1’s role as a survival factor but also identify potential vulnerabilities amenable to therapeutic targeting."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "33"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nFinally, crosstalk between PIM1 and other signaling kinases further amplifies its action. For instance, interaction with the tyrosine kinase Etk in response to IL-6 stimulation can lead to enhanced androgen receptor activation in prostate cancer cells, thereby reinforcing mitogenic and survival signals."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "35"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Kevin C Qian, Lian Wang, Eugene R Hickey, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Structural basis of constitutive activity and a unique nucleotide binding mode of human Pim-1 kinase."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M409123200"}], "href": "https://doi.org/10.1074/jbc.M409123200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15525646"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15525646"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Marc D Jacobs, James Black, Olga Futer, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Pim-1 ligand-bound structures reveal the mechanism of serine/threonine kinase inhibition by LY294002."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M413155200"}], "href": "https://doi.org/10.1074/jbc.M413155200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15657054"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15657054"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Abhinav Kumar, Valsan Mandiyan, Yoshihisa Suzuki, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Crystal structures of proto-oncogene kinase Pim1: a target of aberrant somatic hypermutations in diffuse large cell lymphoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Mol Biol (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.jmb.2005.02.039"}], "href": "https://doi.org/10.1016/j.jmb.2005.02.039"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15808862"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15808862"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Alex N Bullock, Judit Debreczeni, Ann L Amos, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Structure and substrate specificity of the Pim-1 kinase."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M510711200"}], "href": "https://doi.org/10.1074/jbc.M510711200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16227208"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16227208"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Amit Arora, Beatrix Suess "}, {"type": "b", "children": [{"type": "t", "text": "An RNA G-quadruplex in the 3' UTR of the proto-oncogene PIM1 represses translation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "RNA Biol (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.4161/rna.8.5.16038"}], "href": "https://doi.org/10.4161/rna.8.5.16038"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21734463"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21734463"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Daisuke Morishita, Ryohei Katayama, Kazuhisa Sekimizu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Pim kinases promote cell cycle progression by phosphorylating and down-regulating p27Kip1 at the transcriptional and posttranscriptional levels."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/0008-5472.CAN-08-0634"}], "href": "https://doi.org/10.1158/0008-5472.CAN-08-0634"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18593906"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18593906"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Yandong Zhang, Zeping Wang, Nancy S Magnuson "}, {"type": "b", "children": [{"type": "t", "text": "Pim-1 kinase-dependent phosphorylation of p21Cip1/WAF1 regulates its stability and cellular localization in H1299 cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cancer Res (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/1541-7786.MCR-06-0388"}], "href": "https://doi.org/10.1158/1541-7786.MCR-06-0388"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17855660"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17855660"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Malte Bachmann, Hanjo Hennemann, Pei Xiang Xing, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The oncogenic serine/threonine kinase Pim-1 phosphorylates and inhibits the activity of Cdc25C-associated kinase 1 (C-TAK1): a novel role for Pim-1 at the G2/M cell cycle checkpoint."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M404440200"}], "href": "https://doi.org/10.1074/jbc.M404440200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15319445"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15319445"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Andrew Macdonald, David G Campbell, Rachel Toth, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Pim kinases phosphorylate multiple sites on Bad and promote 14-3-3 binding and dissociation from Bcl-XL."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "BMC Cell Biol (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/1471-2121-7-1"}], "href": "https://doi.org/10.1186/1471-2121-7-1"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16403219"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16403219"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "K Nihira, Y Ando, T Yamaguchi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Pim-1 controls NF-kappaB signalling by stabilizing RelA/p65."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Death Differ (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/cdd.2009.174"}], "href": "https://doi.org/10.1038/cdd.2009.174"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19911008"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19911008"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Alessio Zippo, Alessandra De Robertis, Riccardo Serafini, et al. "}, {"type": "b", "children": [{"type": "t", "text": "PIM1-dependent phosphorylation of histone H3 at serine 10 is required for MYC-dependent transcriptional activation and oncogenic transformation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Cell Biol (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/ncb1618"}], "href": "https://doi.org/10.1038/ncb1618"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17643117"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17643117"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Dai Horiuchi, Roman Camarda, Alicia Y Zhou, et al. "}, {"type": "b", "children": [{"type": "t", "text": "PIM1 kinase inhibition as a targeted therapy against triple-negative breast tumors with elevated MYC expression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Med (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/nm.4213"}], "href": "https://doi.org/10.1038/nm.4213"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27775705"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27775705"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Marina Zemskova, Eva Sahakian, Svetlana Bashkirova, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The PIM1 kinase is a critical component of a survival pathway activated by docetaxel and promotes survival of docetaxel-treated prostate cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M709479200"}], "href": "https://doi.org/10.1074/jbc.M709479200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18426800"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18426800"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Fara Brasó-Maristany, Simone Filosto, Steven Catchpole, et al. "}, {"type": "b", "children": [{"type": "t", "text": "PIM1 kinase regulates cell death, tumor growth and chemotherapy response in triple-negative breast cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Med (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/nm.4198"}], "href": "https://doi.org/10.1038/nm.4198"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27775704"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27775704"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Yingqiu Xie, Kexin Xu, Douglas E Linn, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The 44-kDa Pim-1 kinase phosphorylates BCRP/ABCG2 and thereby promotes its multimerization and drug-resistant activity in human prostate cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M707773200"}], "href": "https://doi.org/10.1074/jbc.M707773200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18056989"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18056989"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Gerlinde Wernig, Jeffrey R Gonneville, Brian J Crowley, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The Jak2V617F oncogene associated with myeloproliferative diseases requires a functional FERM domain for transformation and for expression of the Myc and Pim proto-oncogenes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Blood (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1182/blood-2007-07-102186"}], "href": "https://doi.org/10.1182/blood-2007-07-102186"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18216297"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18216297"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Kate Petersen Shay, Zeping Wang, Pei-Xiang Xing, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Pim-1 kinase stability is regulated by heat shock proteins and the ubiquitin-proteasome pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cancer Res (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/1541-7786.MCR-04-0192"}], "href": "https://doi.org/10.1158/1541-7786.MCR-04-0192"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15798097"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15798097"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "John A Muraski, Marcello Rota, Yu Misao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Pim-1 regulates cardiomyocyte survival downstream of Akt."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Med (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/nm1671"}], "href": "https://doi.org/10.1038/nm1671"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18037896"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18037896"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Fang Cheng, Magdalena Weidner-Glunde, Markku Varjosalo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "KSHV reactivation from latency requires Pim-1 and Pim-3 kinases to inactivate the latency-associated nuclear antigen LANA."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS Pathog (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.ppat.1000324"}], "href": "https://doi.org/10.1371/journal.ppat.1000324"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19266083"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19266083"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Christopher T Cottage, Brandi Bailey, Kimberlee M Fischer, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Cardiac progenitor cell cycling stimulated by pim-1 kinase."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Circ Res (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1161/CIRCRESAHA.109.208629"}], "href": "https://doi.org/10.1161/CIRCRESAHA.109.208629"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20075333"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20075333"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "M Thomas, K Lange-Grünweller, U Weirauch, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The proto-oncogene Pim-1 is a target of miR-33a."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/onc.2011.278"}], "href": "https://doi.org/10.1038/onc.2011.278"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21743487"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21743487"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Guoqiang Zhang, Zengyan Liu, Guanghe Cui, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-486-5p targeting PIM-1 suppresses cell proliferation in breast cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Tumour Biol (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s13277-014-2412-0"}], "href": "https://doi.org/10.1007/s13277-014-2412-0"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25104088"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25104088"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Danni Deng, Lei Wang, Yao Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-124-3p regulates cell proliferation, invasion, apoptosis, and bioenergetics by targeting PIM1 in astrocytoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Sci (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/cas.12946"}], "href": "https://doi.org/10.1111/cas.12946"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27088547"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27088547"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Zhiyuan Li, Fang Lin, Changhua Zhuo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "PIM1 kinase phosphorylates the human transcription factor FOXP3 at serine 422 to negatively regulate its activity under inflammation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M114.586651"}], "href": "https://doi.org/10.1074/jbc.M114.586651"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25096571"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25096571"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Svetlana A Didichenko, Nicole Spiegl, Thomas Brunner, et al. "}, {"type": "b", "children": [{"type": "t", "text": "IL-3 induces a Pim1-dependent antiapoptotic pathway in primary human basophils."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Blood (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1182/blood-2008-04-149419"}], "href": "https://doi.org/10.1182/blood-2008-04-149419"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18768389"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18768389"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Alexander Valdman, Xiaolei Fang, See-Tong Pang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Pim-1 expression in prostatic intraepithelial neoplasia and human prostate cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Prostate (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/pros.20064"}], "href": "https://doi.org/10.1002/pros.20064"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15264249"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15264249"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Ulrike Weirauch, Nadine Beckmann, Maren Thomas, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Functional role and therapeutic potential of the pim-1 kinase in colon carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neoplasia (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1593/neo.13172"}], "href": "https://doi.org/10.1593/neo.13172"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23814490"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23814490"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Katriina Peltola, Maija Hollmen, Sanna-Mari Maula, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Pim-1 kinase expression predicts radiation response in squamocellular carcinoma of head and neck and is under the control of epidermal growth factor receptor."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neoplasia (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1593/neo.81038"}], "href": "https://doi.org/10.1593/neo.81038"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19568408"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19568408"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "Carolin Reiser-Erkan, Mert Erkan, Zheng Pan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Hypoxia-inducible proto-oncogene Pim-1 is a prognostic marker in pancreatic ductal adenocarcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Biol Ther (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.4161/cbt.7.9.6418"}], "href": "https://doi.org/10.4161/cbt.7.9.6418"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18708761"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18708761"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "Hao Gu, Mingzhu Liu, Changmao Ding, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Hypoxia-responsive miR-124 and miR-144 reduce hypoxia-induced autophagy and enhance radiosensitivity of prostate cancer cells via suppressing PIM1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Med (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/cam4.664"}], "href": "https://doi.org/10.1002/cam4.664"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26990493"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26990493"}]}, {"type": "r", "ref": 31, "children": [{"type": "t", "text": "Daniel Ribeiro, Alice Melão, Ruben van Boxtel, et al. "}, {"type": "b", "children": [{"type": "t", "text": "STAT5 is essential for IL-7-mediated viability, growth, and proliferation of T-cell acute lymphoblastic leukemia cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Blood Adv (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1182/bloodadvances.2018021063"}], "href": "https://doi.org/10.1182/bloodadvances.2018021063"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30185437"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30185437"}]}, {"type": "r", "ref": 32, "children": [{"type": "t", "text": "Roxane Paulin, Audrey Courboulin, Jolyane Meloche, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Signal transducers and activators of transcription-3/pim1 axis plays a critical role in the pathogenesis of human pulmonary arterial hypertension."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Circulation (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1161/CIRCULATIONAHA.110.963314"}], "href": "https://doi.org/10.1161/CIRCULATIONAHA.110.963314"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21382889"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21382889"}]}, {"type": "r", "ref": 33, "children": [{"type": "t", "text": "Carol Hogan, Caroline Hutchison, Lynnette Marcar, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Elevated levels of oncogenic protein kinase Pim-1 induce the p53 pathway in cultured cells and correlate with increased Mdm2 in mantle cell lymphoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M709695200"}], "href": "https://doi.org/10.1074/jbc.M709695200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18467333"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18467333"}]}, {"type": "r", "ref": 34, "children": [{"type": "t", "text": "Joseph M Gozgit, Geraldine Bebernitz, Pankaj Patil, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Effects of the JAK2 inhibitor, AZ960, on Pim/BAD/BCL-xL survival signaling in the human JAK2 V617F cell line SET-2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M803813200"}], "href": "https://doi.org/10.1074/jbc.M803813200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18775810"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18775810"}]}, {"type": "r", "ref": 35, "children": [{"type": "t", "text": "Oekyung Kim, Tianyun Jiang, Yingqiu Xie, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Synergism of cytoplasmic kinases in IL6-induced ligand-independent activation of androgen receptor in prostate cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/sj.onc.1207304"}], "href": "https://doi.org/10.1038/sj.onc.1207304"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "14981536"}], "href": "https://pubmed.ncbi.nlm.nih.gov/14981536"}]}]}]}